SCA3 (ATXN3) Genetic Testing (Repeat Expansion)
Use
Spinocerebellar ataxias (SCAs), and episodic ataxias are the most common types of autosomal dominant cerebellar ataxias (ADCAs). SCAs are numbered based upon upon their time of identification. SCA3 is the most common type of SCA worldwide, followed by SCA2, SCA1, and SCA6. Some of the complicated forms have not been given a SCA number, like Dentatorubral Pallidoluysian Atrophy (DRPLA). Anticipation can be observed in the autosomal dominant ataxias in which CAG trinucleotide repeats occur. Anticipation results from expansion in the number of CAG repeats with transmission of the gene to subsequent generations. Most ADCAs have an overlap in clinical presentation, which makes it hard to differentiate. The most frequent clinical symptoms in all ADCAs are progressive adult-onset gait ataxia (often with hand dysmetria), and dysarthria associated with cerebellar atrophy. The episodic ataxias are characterized by periods of unsteady gait and often associated with nystagmus or dysarthria. Myokymia, vertigo, or hearing loss may occur in some of the subtypes. Permanent ataxia and even cerebellar atrophy may result late in the disease course.
Special Instructions
When collecting a specimen, it is critical to use the appropriate container and follow the provided instructions to prevent rejection due to improper container use or inadequate specimen quantity.
Limitations
This genetic test may yield false positive or false negative outcomes. Limitations stem from factors such as insufficient data on rare genetic variants, allele dropout, previous blood transfusions, bone marrow transplants, and the presence of somatic or tissue mosaicism. Incorrectly labeled samples may also affect results. Additionally, there is a maximum threshold for reportable repeat expansion, beyond which repeat sizes are stated as greater than the limit.
Methodology
PCR-based (PCR)
Biomarkers
Result Turnaround Time
14-28 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
4 mL
Minimum Volume
2 mL
Container
lavender-top (EDTA) tube
Collection Instructions
standard phlebotomy
Storage Instructions
Maintain specimen at room temperature or refrigerate at 4°C. Do not freeze.
Causes for Rejection
Frozen or hemolyzed specimen; quantity not sufficient for analysis; improper container
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 30 days |
| Frozen | do not freeze |
